v3.25.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2023
Statement of Cash Flows [Abstract]      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 1,718 $ 1,873 $ 1,771
Operating activities:      
Net income (loss) 50 443  
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of premiums and discounts on mortgage-backed securities, net 39 37  
Stock based compensation (4) (1)  
Loss on sale of investment securities, net 245 91  
Unrealized (gain) loss on investment securities measured at fair value through net income, net (1,183) 471  
(Gain) loss on derivative instruments and other securities, net 1,019 (1,059)  
(Increase) decrease in other assets (17) 797  
Increase (decrease) in other liabilities 43 (759)  
Net cash provided by operating activities 192 20  
Investing activities:      
Purchases of Agency mortgage-backed securities (6,878) (6,337)  
Purchases of credit risk transfer and non-Agency securities and other mortgage credit investments (41) (84)  
Proceeds from sale of Agency mortgage-backed securities 2,199 5,060  
Proceeds from sale of credit risk transfer and non-Agency securities 52 62  
Principal collections on Agency mortgage-backed securities 1,538 1,065  
Principal collections on credit risk transfer and non-Agency securities 6 12  
Payments on U.S. Treasury securities (9,578) (3,387)  
Proceeds from Sale of U.S. Treasury securities 7,818 4,446  
Net payments on reverse repurchase agreements (261) (644)  
Net proceeds from (payments on) derivative instruments (582) 389  
Net cash provided by (used in) investing activities (5,727) 582  
Financing activities:      
Proceeds from repurchase arrangements 1,523,750 1,140,681  
Payments on repurchase agreements (1,518,410) (1,141,136)  
Payments on debt of consolidated variable interest entities (4) (4)  
Net proceeds from common stock issuance 509 241  
Cash dividends paid (363) (282)  
Net cash provided by (used in) financing activities 5,482 (500)  
Net change in cash and cash equivalents (53) 102  
Cash and cash equivalents at end of period 455 505  
Supplemental disclosure to cash flow information:      
Restricted Cash and Cash Equivalent $ 1,263 $ 1,368